Clinical Trials Browser

Interventional × tazemetostat × Other solid neoplasm × Clear all

Solid Tumor

NCT02875548 2025-11-04

TRuST

Phase 1/2 Completed

58 enrolled

LymphoidOther solid neoplasmSarcomaThoracic

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Mesothelioma, Sarcoma, Synovial, Lymphoma, Large B-Cell, Diffuse

NCT04537715 2025-02-19

Effects of Itraconazole and Rifampin on the Blood Tazemetostat Levels

Phase 1 Completed

42 enrolled 39 charts

LymphoidOther hematologic neoplasmOther solid neoplasmSarcomaThoracic

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Mesothelioma, Sarcoma, Sarcoma, Synovial, Lymphoma, Large B-Cell, Diffuse, Rhabdoid Tumor, Hematologic Neoplasms

NCT02860286 2021-04-09

Study of the EZH2 Inhibitor Tazemetostat in Malignant Mesothelioma

Phase 2 Completed

74 enrolled 23 charts

Other solid neoplasmThoracic

Mesothelioma

Clinical Trials

Phase II Study of Tazemetostat in Solid Tumors Harboring an ARID1A Mutation

TRuST

Effects of Itraconazole and Rifampin on the Blood Tazemetostat Levels

Study of the EZH2 Inhibitor Tazemetostat in Malignant Mesothelioma